These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 2770002

  • 1. [Targeting to tumor site by the conjugate of antitumor drug with synthetic polymer].
    Hirano T, Ohashi S, Todoroki T, Inaba M, Tsukagoshi S.
    Nihon Rinsho; 1989 Jun; 47(6):1412-6. PubMed ID: 2770002
    [No Abstract] [Full Text] [Related]

  • 2. [Antitumor activity of polyanion and its application for drug delivery system of antitumor drugs].
    Hirano T, Ohashi S, Todoroki T, Inaba M, Tsukagoshi S.
    Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 2):542-7. PubMed ID: 2138872
    [Abstract] [Full Text] [Related]

  • 3. [Antitumor drug delivery system: the progress of researches on block copolymer micelle and its compositive materials].
    Yan K, Wang C.
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2009 Aug; 26(4):927-30. PubMed ID: 19813642
    [Abstract] [Full Text] [Related]

  • 4. Increased therapeutic efficacy and reduced toxicity of doxorubicin linked to pyran copolymer via the side chain of the drug.
    Zunino F, Pratesi G, Pezzoni G.
    Cancer Treat Rep; 1987 Apr; 71(4):367-73. PubMed ID: 3829013
    [Abstract] [Full Text] [Related]

  • 5. [The cross resistance to cytostatics of leukemia P388 cells with induced resistance to doxorubicin].
    Donenko FV, Sitdikova SM, Kabieva AO.
    Biull Eksp Biol Med; 1993 Sep; 116(9):309-11. PubMed ID: 8118011
    [Abstract] [Full Text] [Related]

  • 6. [Targeting therapy of cancer using monoclonal antibody-antitumor drug conjugate].
    Yachi A, Imai K, Hirata H, Hishikawa N.
    Nihon Rinsho; 1989 Jun; 47(6):1391-5. PubMed ID: 2475654
    [No Abstract] [Full Text] [Related]

  • 7. [Result of antineoplastic agents screening: 7th report].
    Gan To Kagaku Ryoho; 1998 Mar; 25 Suppl 2():147-392. PubMed ID: 9551093
    [No Abstract] [Full Text] [Related]

  • 8. Polymer-protein and polymer-drug conjugates in cancer therapy.
    Thanou M, Duncan R.
    Curr Opin Investig Drugs; 2003 Jun; 4(6):701-9. PubMed ID: 12901229
    [Abstract] [Full Text] [Related]

  • 9. Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect.
    Maeda H, Bharate GY, Daruwalla J.
    Eur J Pharm Biopharm; 2009 Mar; 71(3):409-19. PubMed ID: 19070661
    [Abstract] [Full Text] [Related]

  • 10. [Mechanisms of the antitumor action of spirobromine in mice with leukemia P-388].
    Sokolova IS, Riabokon' NA, Chernov VA, Gorbacheva LB.
    Izv Akad Nauk SSSR Biol; 1989 Mar; (5):660-5. PubMed ID: 2584530
    [Abstract] [Full Text] [Related]

  • 11. Optimization of (1,2-diamino-cyclohexane)platinum(II)-loaded polymeric micelles directed to improved tumor targeting and enhanced antitumor activity.
    Cabral H, Nishiyama N, Kataoka K.
    J Control Release; 2007 Aug 28; 121(3):146-55. PubMed ID: 17628162
    [Abstract] [Full Text] [Related]

  • 12. Stability of the in vivo P388 leukemia model in evaluation of antitumor activity of natural products.
    Marsh JC, Shoemaker RH, Suffness M.
    Cancer Treat Rep; 1985 Jun 28; 69(6):683-5. PubMed ID: 4016772
    [Abstract] [Full Text] [Related]

  • 13. Tumour-targeted drug and gene delivery: principles and concepts.
    Cassidy J, Schätzlein AG.
    Expert Rev Mol Med; 2004 Sep 13; 6(19):1-17. PubMed ID: 15387893
    [Abstract] [Full Text] [Related]

  • 14. Experimental studies and preliminary clinical trial of vinorelbine-loaded polymeric bioresorbable implants for the local treatment of solid tumors.
    Fournier C, Hecquet B, Bouffard P, Vert M, Caty A, Vilain MO, Vanseymortier L, Merle S, Krikorian A, Lefebvre JL.
    Cancer Res; 1991 Oct 01; 51(19):5384-91. PubMed ID: 1913658
    [Abstract] [Full Text] [Related]

  • 15. Conjugates of doxorubicin with graft HPMA copolymers for passive tumor targeting.
    Etrych T, Chytil P, Mrkvan T, Sírová M, Ríhová B, Ulbrich K.
    J Control Release; 2008 Dec 18; 132(3):184-92. PubMed ID: 18534705
    [Abstract] [Full Text] [Related]

  • 16. [Damage to the supramolecular DNA complex in the mechanism of action of antitumor drugs].
    Blokhin DIu.
    Vopr Onkol; 1985 Dec 18; 31(11):60-6. PubMed ID: 4072085
    [Abstract] [Full Text] [Related]

  • 17. Clinical applications of magnetic drug targeting.
    Lübbe AS, Alexiou C, Bergemann C.
    J Surg Res; 2001 Feb 18; 95(2):200-6. PubMed ID: 11162046
    [Abstract] [Full Text] [Related]

  • 18. Relationship between in vitro tumor stem cell assay and in vivo antitumor activity using the P388 leukemia.
    Marsh JC, Shoemaker RH, Salmon SE, Kern DH, Venditti JM.
    Int J Cell Cloning; 1988 Jan 18; 6(1):60-8. PubMed ID: 3339266
    [Abstract] [Full Text] [Related]

  • 19. Polymeric anticancer drugs with pH-controlled activation.
    Ulbrich K, Etrych T, Chytil P, Pechar M, Jelinkova M, Rihova B.
    Int J Pharm; 2004 Jun 11; 277(1-2):63-72. PubMed ID: 15158969
    [Abstract] [Full Text] [Related]

  • 20. [Antitumor effects of a new antitumor agent, zinostatin stimalamer (YM881)--effects on experimental tumors in vitro and in vivo].
    Numasaki Y, Takahashi K, Masuda E, Nohara C, Maeda H.
    Gan To Kagaku Ryoho; 1991 Oct 11; 18(13):2289-94. PubMed ID: 1834021
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.